We source premium, research-backed ingredients, including patented Eriomin , PreticX , and Yestein
The GLP-1 Craze and Laziness: A Cautionary Conversation | Kansas City Laser-Like Lipo July 16, 2025 The GLP-1 Craze: A Cautionary Conversation | Kansas City Laser-Like Lipo Photo Credit: Shutterstock At Kansas City Laser-Like Lipo, we've noticed that over 14 million Americans currently use GLP-1 weight-loss injections like Ozempic, Wegovy, and Mounjaro
Tirzepatide is a dual GIP and GLP-1 receptor agonist with a long pharmacological half-life
Patients considering a mid-treatment switch should discuss the transition with their current provider and inform their new provider of their complete treatment history to ensure continuity of dosing and monitoring
In a 1-year study of people with obesity or overweight, people taking tirzepatide were more than twice as likely to lose at least 10% of their body weight, and more than three times as likely to lose at least 15% of their body weight, than those taking semaglutide